# Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

> **NCT06099730** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Pulsed Field Ablation (PFA)

## Key facts

- **NCT ID:** NCT06099730
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-14
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099730, "Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06099730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*